Melanoma is a serious form of cancer that arises when the pigment-producing cells in the skin (melanocytes) may display as a mole or lesion that grows, changes shape, or colour.

About melanoma

Our experts have created specialist resources including comprehensive information on melanoma stages and treatment to help you make informed choices.

We have a professional membership for clinicians, scientists and nurses in the field of melanoma. We provide key educational resources, the melanoma TrialFinder and research grants, in addition to organising two multidisciplinary meetings each year.

For professionals

We know there is more that can be done to stop melanoma and the suffering it causes, but we need your help.

Get involved

As experts in melanoma, we provide information, guidance and support for patients, carers and healthcare professionals. We have built a community of melanoma specialists who underpin our commitment to melanoma education and research.

About us

UK Patient Feedback

January 2023

Melanoma Focus have been invited by the Scottish Medicines Consortium to provide patient feedback to support the review of pembrolizumab in stage 2B and 2C melanoma in Scotland. This treatment has already been approved for this indication by NICE [TA837] and published in October 2022. If you have been treated with pembrolizumab (or an alternative treatment) in the UK for stage 2B or 2C melanoma (within a trial or since NICE approved), we invite you to complete the short questionnaire which should take about 10 minutes to complete – thank you.

This survey is now closed thank you for taking the time to complete it!